The molecular biology of chronic wounds and delayed healing in diabetes

被引:471
作者
Blakytny, R.
Jude, E.
机构
[1] Tameside Gen Hosp, Ctr Diabet, Ahston Under Lyne OL6 9RW, Lancs, England
[2] Fachklin Hornheide, Munster, Germany
关键词
chronic wounds; growth factors; matrix metalloproteinases; nitric oxide; wound healing;
D O I
10.1111/j.1464-5491.2006.01773.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Wound healing is a complicated and integrated process. Although there is some tolerance in terms of redundancy and interrelated control mechanisms, pushing beyond such limits may contribute to delayed wound healing, and in extreme cases lead to chronic wounds/ulcers and thus potentially to lower extremity amputation. Diabetes is associated with such disruption in wound healing. Research in humans and in animal models has identified a large number of changes associated with diabetes at the molecular level in delayed wound healing and to a lesser extent in chronic diabetic ulcers. Better overall understanding of these changes and how they are interrelated would allow for specifically targeted treatment, thus ensuring improved quality of life for patients and providing savings to the high costs that are associated with all aspects of chronic diabetic ulcers. This review examines the work done at the molecular level on chronic diabetic ulcers, as well as considering changes seen in diabetes in general, both in humans and animal models, that may in turn contribute to ulcer formation.
引用
收藏
页码:594 / 608
页数:15
相关论文
共 225 条
[1]  
Abd-El-Aleem SA, 2000, J PATHOL, V191, P434, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH654>3.0.CO
[2]  
2-S
[3]   Lower-extremity amputation in diabetes - The independent effects of peripheral vascular disease, sensory neuropathy, and foot ulcers [J].
Adler, AI ;
Boyko, EJ ;
Ahroni, JH ;
Smith, DG .
DIABETES CARE, 1999, 22 (07) :1029-1035
[4]   Advanced glycation endproducts - role in pathology of diabetic complications [J].
Ahmed, N .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2005, 67 (01) :3-21
[5]  
ALBINA JE, 1990, J IMMUNOL, V144, P3877
[6]   Inhibition of lipid peroxidation restores impaired vascular endothelial growth factor expression and stimulates wound healing and angiogenesis in the genetically diabetic mouse [J].
Altavilla, D ;
Saitta, A ;
Cucinotta, D ;
Galeano, M ;
Deodato, B ;
Colonna, M ;
Torre, V ;
Russo, G ;
Sardella, A ;
Urna, G ;
Campo, GM ;
Cavallari, V ;
Squadrito, G ;
Squadrito, F .
DIABETES, 2001, 50 (03) :667-674
[7]   The role of endogenous nerve growth factor in human diabetic neuropathy [J].
Anand, P ;
Terenghi, G ;
Warner, G ;
Kopelman, P ;
WilliamsChestnut, RE ;
Sinicropi, DV .
NATURE MEDICINE, 1996, 2 (06) :703-707
[8]   BIOMECHANICAL CHANGES IN CONNECTIVE TISSUES INDUCED BY EXPERIMENTAL DIABETES [J].
ANDREASSEN, TT ;
SEYERHANSEN, K ;
OXLUND, H .
ACTA ENDOCRINOLOGICA, 1981, 98 (03) :432-436
[9]   Skin nervous system interactions [J].
Ansel, JC ;
Kaynard, AH ;
Armstrong, CA ;
Olerud, J ;
Bunnett, N ;
Payan, D .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1996, 106 (01) :198-204
[10]   Neutral endopeptidase activity is increased in the skin of subjects with diabetic ulcers [J].
Antezana, MA ;
Sullivan, SR ;
Usui, ML ;
Gibran, NS ;
Spenny, ML ;
Larsen, JA ;
Ansel, JC ;
Bunnett, NW ;
Olerud, JE .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 119 (06) :1400-1404